Voyager Therapeutics: Q4 Earnings Snapshot

LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Voyager Therapeutics Inc. (VYGR) on Wednesday reported fourth-quarter net income of $56.4 million.

The Lexington, Massachusetts-based company said it had net income of $1.25 per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.

The gene therapy company posted revenue of $90.1 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $4.9 million.

For the year, the company reported profit of $132.3 million, or $2.97 per share. Revenue was reported as $250 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VYGR at https://www.zacks.com/ap/VYGR